{"id":118704,"date":"2021-01-20T14:22:34","date_gmt":"2021-01-20T22:22:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/01\/nhs-patients-among-first-to-access-new-car-t-cell-therapy-for-lymphoma"},"modified":"2021-01-20T14:22:34","modified_gmt":"2021-01-20T22:22:34","slug":"nhs-patients-among-first-to-access-new-car-t-cell-therapy-for-lymphoma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/01\/nhs-patients-among-first-to-access-new-car-t-cell-therapy-for-lymphoma","title":{"rendered":"NHS patients among first to access new CAR T cell therapy for lymphoma"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/nhs-patients-among-first-to-access-new-car-t-cell-therapy-for-lymphoma.jpg\"><\/a><\/p>\n<p>NHS clinicians in England will be among the first to offer a cutting-edge personalised cancer treatment to some people with lymphoma, after the CAR T cell therapy was approved for NHS use.<\/p>\n<p>Tecartus \u2013 a immune-boosting treatment that engineers a patient\u2019s own immune cells to kill their cancer \u2013 has been <a href=\"https:\/\/www.nice.org.uk\/guidance\/gid-ta10312\/documents\/html-content-2\">recommended by the National Institute for Health and Care Excellence (NICE)<\/a> for people with a rare type of non-Hodgkin lymphoma.<\/p>\n<p>NICE estimates that around 100 people a year with <a href=\"https:\/\/www.cancerresearchuk.org\/about-cancer\/non-hodgkin-lymphoma\/types\/mantle-cell\">mantle cell lymphoma<\/a> could be treated with this therapy. Kruti Shrotri, head of policy development at Cancer Research UK, said the news will be welcomed by people with mantle cell lymphoma.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NHS clinicians in England will be among the first to offer a cutting-edge personalised cancer treatment to some people with lymphoma, after the CAR T cell therapy was approved for NHS use. Tecartus \u2013 a immune-boosting treatment that engineers a patient\u2019s own immune cells to kill their cancer \u2013 has been recommended by the National [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,31],"tags":[],"class_list":["post-118704","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-policy"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/118704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=118704"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/118704\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=118704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=118704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=118704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}